Literature DB >> 15598260

Clinical microbicide research: an overview.

Lut Van Damme1.   

Abstract

At the end of 2003, 42 million people were HIV infected and the epidemic continues to spread, despite the availability and effectiveness of male condoms. For many women negotiating condom use is not feasible. Therefore there is an urgent need for a female controlled method for HIV prevention. This article gives an overview of the clinical research done with microbicides, chemicals with the potential to prevent an HIV infection. In the 1990s most research was done with spermicides, mainly nonoxynol-9. Since the results of the COL-1492 trial became available, new products were evaluated and some of them are now in phase III trials.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15598260     DOI: 10.1111/j.1365-3156.2004.01338.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  7 in total

1.  Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms.

Authors:  Timothy M Hanley; Gregory A Viglianti
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

2.  Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.

Authors:  Hencelyn Chu; Anatoly Slepenkin; Mikael Elofsson; Pia Keyser; Luis M de la Maza; Ellena M Peterson
Journal:  Int J Antimicrob Agents       Date:  2010-06-01       Impact factor: 5.283

3.  In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1.

Authors:  Mohammad M Hossain; Michael A Parniak
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.

Authors:  Daniela Romer; David W Brighty; Cynthia L Robson; Quentin J Sattentau
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

5.  In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories.

Authors:  Brigitte E Beer; Gustavo F Doncel; Fred C Krebs; Robin J Shattock; Patricia S Fletcher; Robert W Buckheit; Karen Watson; Charlene S Dezzutti; James E Cummins; Ena Bromley; Nicola Richardson-Harman; Luke A Pallansch; Carol Lackman-Smith; Clay Osterling; Marie Mankowski; Shendra R Miller; Bradley J Catalone; Patricia A Welsh; Mary K Howett; Brian Wigdahl; Jim A Turpin; Patricia Reichelderfer
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

6.  Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates.

Authors:  Irina A Zalenskaya; Theresa Joseph; Jasmin Bavarva; Nazita Yousefieh; Suzanne S Jackson; Titilayo Fashemi; Hidemi S Yamamoto; Robert Settlage; Raina N Fichorova; Gustavo F Doncel
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

7.  Effect of antimicrobial Peptide, nisin, on the reproductive functions of rats.

Authors:  K V R Reddy; S M Gupta; C C Aranha
Journal:  ISRN Vet Sci       Date:  2012-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.